Ceo
CurrentAmprion focuses on highly sensitive, early detection of misfolded prion proteins responsible for progressive neurodegeneration in Alzheimer's, Parkinson's and other CNS degenerative diseases. Amprion's mission is to end Alzheimer's and Parkinson's through early molecular detection plus accelerated development of effective treatments.